Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127377 Chlorinated vinblastine as anticancer chemotherapy drug
10/03/2000US6127376 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
10/03/2000US6127375 A 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthiones for treating viral infection
10/03/2000US6127373 Method of treating tourette's syndrome and obsessive compulsive disorder
10/03/2000US6127372 Sulfonamide inhibitors of aspartyl protease
10/03/2000US6127371 Endothelin receptor antagonists
10/03/2000US6127370 Method for treating alzheimer's disease
10/03/2000US6127369 For treating carcinoma, leukemia, melanoma, neuroblastoma
10/03/2000US6127368 Anellated β-carbolines
10/03/2000US6127367 Administering an aldose reductase inhibitor as an antiischemic agent
10/03/2000US6127365 Tachykinin antagonists for treatment of pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/03/2000US6127363 Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
10/03/2000US6127362 9,10-diazatricyclo[4,4,1,12,5 ] decane and 2,7-diazatricyclo [4,4,0,03,8 ] decane derivatives having analgesic activity
10/03/2000US6127360 Antihistamines, antileukotrienes, antiinflammatory agents, antiasthmatic agents
10/03/2000US6127358 Purification by membrane microfiltration, then ultrafiltration
10/03/2000US6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides
10/03/2000US6127356 Modulating intra- or extracellular levels of oxidants such as superoxide radicals, hydrogen peroxide and peroxynitrites by using low molecular weight mimetics of superoxide dismutase, catalase or peroxidase
10/03/2000US6127355 High molecular weight polymer-based prodrugs
10/03/2000US6127354 For treatment of growth disorders or to stimulate production of wool or milk
10/03/2000US6127353 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
10/03/2000US6127352 Relieving pain by administering mixtures containing lower concentrations of codeine and higher concentrations of either acetyl salicyclic acid or acetaminophen
10/03/2000US6127351 Method for the administration of amifostine and related compounds
10/03/2000US6127350 Use of phenol substituted diphosphonates as antineoplastic agents
10/03/2000US6127349 For increasing the water solubility and bioavailability of pharmaceutical agents by conjugation to phospholipids
10/03/2000US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/03/2000US6127347 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
10/03/2000US6127346 For the treatment of viruses
10/03/2000US6127342 Administering gamma-l-glutamyl-l-cysteine esters for treatment or prevention of asthma
10/03/2000US6127338 Three peptides of given amino acid sequences with antihyperglycemic activity; extracts of the fruit momordica charantia
10/03/2000US6127336 Antibacterial and antifungal peptide
10/03/2000US6127335 Cyclic adhesion inhibitors
10/03/2000US6127173 Nucleotide sequence for targeted cleavage of nucleic acids
10/03/2000US6127151 Antigenic preparations and the isolation of such preparations
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6126971 Stable oral CI-981 formulation and process for preparing same
10/03/2000US6126970 Coating of polyvinyl chloride or terpolymer of vinyl chloride, vinyl acetate and vinyl alcohol with pores for water soluble or gastrointestinal fluids
10/03/2000US6126969 Immediate release/sustained release compressed tablets
10/03/2000US6126968 Stable compositions containing N-propargyl-1-aminoindan
10/03/2000US6126966 Liposomes containing a cisplatin compound
10/03/2000US6126962 Crystalline powdery saccharide, its preparation and uses
10/03/2000US6126961 Composition and method for reducing the colonization of animal intestines by salmonella and other bacterial pathogens
10/03/2000US6126959 Pharmaceutical composition for treating dysmenorrhea and premature labor
10/03/2000US6126957 Ticrynafen or indacrinone in an amount effective to lower interocular pressure
10/03/2000US6126956 Subcutaneous implant
10/03/2000US6126951 Silicone-free carbon based replacements for the volatile cyclomethicones.
10/03/2000US6126947 Method for the treatment of skin disorders using inhibitor of cholesterol synthesis
10/03/2000US6126941 Phospholipidic composition, method for the production of such a composition and its use
10/03/2000US6126932 Insoluble polymer bearing pendant side chains, said side chains each terminating with the 1-(3-(1-pyrrolidinyl)-propyl)-3-ethylcarbodiimide moiety.
10/03/2000US6126927 Mixing silicone rubber powder with antiperspirant in liquid carrier; drying
10/03/2000US6126920 Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition
10/03/2000US6126917 Epidermal growth factor receptor binding compounds for positron emission tomography
10/03/2000US6126909 Process and apparatus for the production of BI-212 and a use thereof
10/03/2000US6126832 Composition for dialysis and shock treatment
10/03/2000CA2206463C Silicone compositions
10/03/2000CA2190180C Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders
10/03/2000CA2179746C Novel therapeutic carbohydrate blends useful for aiding premenstrual syndrome
10/03/2000CA2177773C New aryl(alkyl)propylamides, process for preparing the same and pharmaceutical compositions containing them
10/03/2000CA2117046C Liposomal antibiotic formulation
10/03/2000CA2006953C Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
09/2000
09/30/2000CA2302886A1 A stable aqueous solution of em 12
09/28/2000WO2000057190A2 Prediction of diabetes impaired wound healing
09/28/2000WO2000057186A1 Method for detecting predisposition to a venous thromboembolic disease
09/28/2000WO2000057185A1 Method for detecting superantigen activity in a biological sample
09/28/2000WO2000056930A1 Truncation selex method
09/28/2000WO2000056919A1 Screening method involving mgdg synthase
09/28/2000WO2000056918A1 Method for screening cysteine protease inhibitor
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
09/28/2000WO2000056885A1 Protein for blocking platelet adhesion
09/28/2000WO2000056883A1 49 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056760A1 Phenylalanine derivatives
09/28/2000WO2000056757A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056748A1 Xylo-lna analogues
09/28/2000WO2000056743A1 Pharmaceutical compositions comprising metal complexes
09/28/2000WO2000056742A1 Organic-arsenic compounds
09/28/2000WO2000056739A1 Thienopyrimidine compounds, their production and use
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000WO2000056737A2 Calanolides for inhibiting btk
09/28/2000WO2000056736A2 Use of non-nucleoside reverse transcriptase inhibitor (mni) for the treatment of hiv infection
09/28/2000WO2000056734A1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents
09/28/2000WO2000056733A1 Triazolopyrimidinol compounds and salts thereof
09/28/2000WO2000056731A1 Novel method for producing doxazosin mesylate in a crystalline modification designated as form a
09/28/2000WO2000056730A1 PROCESS FOR PREPARING [S-(R*,S*)] -β -[[[1-[1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056728A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000WO2000056727A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000WO2000056726A1 Improved aqueous solubility pharmaceutical formulations
09/28/2000WO2000056724A1 Oxazole and thiazole combinatorial libraries
09/28/2000WO2000056720A1 Quinazolines and therapeutic use thereof
09/28/2000WO2000056719A1 FUSED PYRIDOPYRIDAZINE INHIBITORS OF cGMP PHOSPHODIESTERASE
09/28/2000WO2000056718A1 Imidazole compounds
09/28/2000WO2000056714A1 Novel compounds
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056711A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
1 ... 6236 6237 6238 6239 6240 6241 6242 6243 6244 6245 6246 6247 6248 6249 6250 6251 6252 6253 6254 6255 6256 ... 7860